quality of life

Research in Review

Depression May Cause Decreased Response to Chemotherapy

12/21/2016

JCP Editors

Patients with cancer who are suffering from depression may be less responsive to cancer drugs and less tolerant of their side-effects, a new study shows. ----- Related Content Psychedelic drug psilocybin relieves...

...

12/21/2016

Journal of Clinical Pathways

Research in Review

Stepped Care Program Targeting Psychological Distress Deemed Cost-Effective

12/09/2016

JCP Editors

A stepped care program has been deemed more cost-effective than care-as-usual in patients with head and neck cancer or lung cancer who have psychological distress, according to a recent study published in the Journal...

A...

12/09/2016

Journal of Clinical Pathways

Regret-Based Decision Model Helpful Tool for Palliative Care Discussions

11/30/2016

JCP Editors

The implementation of a regret-based decision model may help patients with terminal blood cancers attain appropriate end-of-life care, according to research presented at the 2016 ASH Annual Meeting and...

The...

11/30/2016

Journal of Clinical Pathways

Research in Review

Glioblastoma Characteristics Provide Evidence for Prognosis, Treatment of Older Patients

11/09/2016

JCP Editors

According to researchers, characteristics of glioblastoma including seizures, location, and pressure in the brain give valuable insight into length of survival as well as treatment options for patients over the age...

...

11/09/2016

Journal of Clinical Pathways

Research in Review

No Difference in Renal Function Decline With ACE inhibitors or ARBs for Diabetes

06/20/2016

JCP Editors

A study comparing the effectivenesses of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) for protecting patients with type 2 diabetes from renal function decline found no...

...

06/20/2016

Journal of Clinical Pathways

06/09/2016

JCP Editors

Health-related quality of life (HRQoL) and its impact on disease progression should be a critical consideration when selecting treatment for patients with soft-tissue sarcoma (STS),...

...

06/09/2016

Journal of Clinical Pathways

Research in Review

Hypofractionation Leads to Greater Toxicity in Patients with Prostate Cancer

03/29/2016

JCP Editors

A new study has failed to demonstrate hypofractionated radiotherapy as a non-inferior option to fractionated radiotherapy for patients with intermediate- or high-risk prostate cancer. In patients with genitourinary...

A new...

03/29/2016

Journal of Clinical Pathways

Patients With Prostate Cancer Report Better QoL With Active Surveillance

03/16/2016

JCP Editors

Active surveillance (AS) for patients with low-risk prostate cancer can provide similar quality of life to that of men living without cancer, according to a study presented at the European Association of Urology...

Active...

03/16/2016

Journal of Clinical Pathways

Interview

Why a Patient-Centered Approach to Clinical Pathways Must Include Palliative Care

02/16/2016

An interview with Geoffrey P Dunn, MD, General Surgeon, UPMC-Hamot, Pittsburgh, PA With the development of ever improving treatments for cancers of all types, the relative 5-year survival rate for all cancers has...

An...

02/16/2016

Journal of Clinical Pathways

Research in Review

Emergency Department‚ÄìInitiated Palliative Care Improves Quality of Life with Advanced Cancer

01/18/2016

JCP Editors

Palliative care consultations initiated in the emergency department (ED) may improve quality of life for advanced cancer patients without shortening survival, according to a recently published study. ED visits are...

...

01/18/2016

Journal of Clinical Pathways